Kalypsys, Inc.

Quick facts

Phase 2 pipeline

• KD7040 Topical Gel · Dermatology
  KD7040 Topical Gel is a topical gel formulation of a small molecule inhibitor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kalypsys, Inc. portfolio CI brief
• Kalypsys, Inc. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies